Form 10-Q Autolus Therapeutics For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Wells Fargo Reiterates Overweight Rating on Autolus Therapeutics plc (AUTL)
May 20, 2024 6:43 AM EDTWells Fargo analyst Yanan Zhu reiterated an Overweight rating and $8.00 price target on Autolus Therapeutics plc (NASDAQ: AUTL).
The analyst comments "We continue to see AUTL as well positioned for upside on 2H24 catalysts incl. B-ALL PDUFA (11/16) and first SLE data (late... More
